Newsfiscal.ai
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006
· Published
Article summary
Sutro Biopharma has initiated a Phase 1 clinical trial for STRO-006, an antibody-drug conjugate targeting integrin β6 for the treatment of solid tumors.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…